Načítá se...
4CPS-039 Allantoin 6% cream in epidermolysis bullosa: a case report
BACKGROUND: Epidermolysis bullosa (EB) is a clinically and genetically heterogeneous group of skin fragility disorders characterised by trauma-induced blister formation for which there is no definitive therapy. Wound care is an important component of management. Allantoin acts as an emollient, heali...
Uloženo v:
| Vydáno v: | Eur J Hosp Pharm |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Group
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535855/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.130 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|